Може ли да ме посъветвате, какво да п... - Fight Prostate Ca...

Fight Prostate Cancer

3,032 members1,512 posts

Може ли да ме посъветвате, какво да предприема?

Vasili profile image
1 Reply

Здравейте, спрях Eligard от преди 1 година, когато тестостерона беше 2.5 ng/dl , PSA 0,01 , скоро започна да се покачва Т 60 ng/dl , PSA 0,07 . С този нов тестостерон се чувствам по добре, но не и в безопасност ???

Може ли да ме посъветвате, какво да предприема?

Written by
Vasili profile image
Vasili
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Seasid profile image
Seasid

Hello, I stopped Eligard a year ago when my testosterone was 2.5 ng/dl and PSA was 0.01. Recently, my testosterone started to rise to 60 ng/dl, and PSA to 0.07. With this new testosterone level, I feel good, but not safe.

Can you advise me on what to do?

ChatGPT said

Not what you're looking for?

You may also like...

First BAT cycle results: what next?

I started my first BAT cycle on 3-12-24, originally designed to last for 32 days. PSA was...

Question in Preparation for pBAT

For those who have experience with BAT: I’m getting ready to start my first 30 day cycle of pBAT...

ASCO 23 - Transdermal square-wave testosterone therapy

This might interest followers of BAT. As you no doubt know, Denmeade's BAT cycle is a 28-day...
pjoshea13 profile image

ASCO Gu 2025: real world data confirms that undetectable PSA nadir is a strong predictor of outcomes

Real world seems to confirm clinical trial data in this case! A real-world study from the IRONMAN...
Maxone73 profile image

Is there any order to when new medications or PARP inhibitor are tried?

My medical oncologist is hell bent on me doing Lu 177 pluvicto next, I was hoping to try other...

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.